Valuation: Balchem Corporation

Market Cap 5.34B 4.67B 4.31B 3.97B 7.48B 514B 7.65B 51.48B 20.25B 252B 20.06B 19.62B 867B P/E 2026 *
31.4x
P/E 2027 * 30.4x
Enterprise Value 5.33B 4.66B 4.3B 3.96B 7.47B 513B 7.63B 51.37B 20.2B 251B 20.01B 19.57B 865B EV / Sales 2026 *
4.81x
EV / Sales 2027 * 4.45x
Free-Float
99.53%
Yield 2026 *
0.69%
Yield 2027 * 0.77%
1 day-1.73%
1 week-0.11%
Current month-3.31%
1 month-0.50%
3 months-6.36%
6 months-3.19%
Current year+6.51%
1 week 159.34
Extreme 159.34
168.91
1 month 159.34
Extreme 159.34
174.09
Current year 152.58
Extreme 152.58
183.9
1 year 139.17
Extreme 139.17
183.9
3 years 110.74
Extreme 110.74
186.03
5 years 110.15
Extreme 110.1456
186.03
10 years 61.03
Extreme 61.03
186.03
Manager TitleAgeSince
Chief Executive Officer 61 28/04/2015
Director of Finance/CFO 49 04/02/2019
Chief Tech/Sci/R&D Officer 56 01/10/2025
Director TitleAgeSince
Director/Board Member 63 16/09/2010
Chairman 61 01/01/2017
Director/Board Member 59 15/09/2015
Date Insider Type Main position Quantity % Market Cap.
4/1/26 A Other

Controller/Auditor

8,646 0.0270%
2/11/26 A Free

Head of Human Resources

8,685 0.0268%
2/11/26 A Free

Chief Executive Officer

62,743 0.1937%
Change 5-day change 1-year change 3-year change Capi.($)
-1.73%-0.11%+3.29%+24.92% 5.34B
-1.04%-0.07%+1.91%+44.77% 77.6B
+0.56%+0.09%-8.99%+14.14% 38.85B
-0.88%-1.71%-21.39%-36.97% 31.72B
+0.25%+2.05%+21.22%+33.75% 26.45B
+0.07%+11.03%+20.63%+9.99% 21.98B
+5.25%-5.78%+92.58%-10.71% 18.95B
+0.74%+0.37%-39.02%-37.89% 18.13B
+1.10%-5.95%+71.54%-48.66% 14.09B
-0.89%+0.11%-0.25%-8.22% 14.02B
Average +0.20%+0.02%+14.15%-1.49% 26.71B
Weighted average by Cap. -0.05%+0.54%+8.25%+9.00%

Financials

2026 *2027 *
Net sales 1.11B 968M 894M 824M 1.55B 107B 1.59B 10.68B 4.2B 52.27B 4.16B 4.07B 180B 1.17B 1.02B 941M 867M 1.63B 112B 1.67B 11.25B 4.42B 55.04B 4.38B 4.29B 189B
Net income 168M 147M 136M 125M 236M 16.2B 241M 1.62B 638M 7.93B 632M 618M 27.31B 174M 152M 140M 129M 243M 16.74B 249M 1.68B 659M 8.2B 653M 638M 28.22B
Net Debt -11.86M -10.37M -9.57M -8.82M -16.62M -1.14B -16.99M -114M -44.97M -559M -44.55M -43.57M -1.93B -153M -134M -124M -114M -215M -14.76B -220M -1.48B -581M -7.23B -576M -563M -24.89B
Logo Balchem Corporation
Balchem Corporation develops, manufactures, distributes and markets specialty performance ingredients and products for nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition and industrial markets. Its segments include Human Nutrition and Health (HNH), Animal Nutrition and Health (ANH), and Specialty Products. The HNH segment provides human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. This segment also manufactures specialty vitamin K2, which plays a role in the human body for bone health, heart health and immunity, and methylsulfonylmethane (MSM). The ANH segment provides nutritional products derived from its microencapsulation and chelation technologies in addition to the nutrient choline chloride. The Specialty Products segment re-packages and distributes a number of gases and chemicals for various uses by its customers, notably ethylene oxide, propylene oxide, and ammonia.
Employees
1,368
Date Price Change Volume
17/07/26 $163.35 -1.73% 170,990
16/07/26 $166.23 +2.17% 230,441
15/07/26 $162.70 +1.14% 170,693
14/07/26 $160.86 -0.36% 172,800
13/07/26 $161.44 -0.44% 250,954
Trader
Investor
Global
Quality
-
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
166.23USD
Average target price
200.75USD
Spread / Average Target
+20.77%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BCPC Stock